Haleon plc
HealthcareNYSE:HLN · New York Stock Exchange
+$0.11 today
Vol 5.95M · Avg 8.66M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$19.3B of revenue converted into $2.8B of net income for the selected period. Gross margin is 63.9% and net margin is 14.5%, showing how much revenue survives after costs and taxes. EPS is $0.62, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.8B -4.0% | $11.2B -0.6% | $11.3B +4.1% | $10.9B +13.8% | $9.5B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $3.8B -11.3% | $4.3B -1.3% | $4.3B +1.4% | $4.3B +19.1% | $3.6B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $7.0B +0.6% | $6.9B -0.2% | $7.0B +5.8% | $6.6B +10.5% | $6.0B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 64.8% +2.9pp | 61.9% +0.3pp | 61.6% +1.0pp | 60.6% -1.8pp | 62.3% | 9.8% | 28.9% | 38.3% |
| Research & Development | $308.1M +3.4% | $298.0M -4.2% | $311.0M +3.7% | $300.0M +16.7% | $257.0M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $4.3B -1.7% | $4.3B +1.0% | $4.3B +6.2% | $4.0B +6.4% | $3.8B | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $4.6B -3.7% | $4.7B -4.5% | $5.0B +4.5% | $4.8B +10.2% | $4.3B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $352.1M +79.6% | $196.0M -36.6% | $309.0M +7.7% | $287.0M +7.1% | $268.0M | $374.2M | $1.2B | $631.8M |
| EBITDA | $2.8B +10.3% | $2.5B +6.9% | $2.4B +7.7% | $2.2B -1.3% | $2.2B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 25.7% +3.3pp | 22.4% +1.6pp | 20.8% +0.7pp | 20.1% -3.1pp | 23.2% | 5.6% | 46.3% | 42.0% |
| Operating Income | $2.4B +9.7% | $2.2B +10.5% | $2.0B +9.4% | $1.8B +11.4% | $1.6B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 22.4% +2.8pp | 19.6% +2.0pp | 17.7% +0.9pp | 16.8% -0.4pp | 17.2% | 16.6% | 24.1% | 22.0% |
| Interest Income | $76.3M +38.7% | $55.0M +292.9% | $14.0M -79.7% | $69.0M +430.6% | $13.0M | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $332.5M -15.6% | $394.0M -4.8% | $414.0M +19.2% | $347.4M +2071.0% | $16.0M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$315.9M -6.7% | -$296.0M +19.6% | -$368.0M -77.8% | -$207.0M -10250.0% | -$2.0M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $2.1B +10.2% | $1.9B +17.3% | $1.6B +0.6% | $1.6B -1.1% | $1.6B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 19.5% +2.5pp | 17.0% +2.6pp | 14.4% -0.5pp | 14.9% -2.2pp | 17.1% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $461.7M +6.1% | $435.0M -15.9% | $517.0M +3.6% | $499.0M +153.3% | $197.0M | $1.3B | -$1.6B | $745.2M |
| Net Income | $1.6B +13.1% | $1.4B +37.5% | $1.0B -1.0% | $1.1B -23.7% | $1.4B | $4.9B | $4.8B | $4.7B |
| Net Margin | 15.1% +2.3pp | 12.8% +3.6pp | 9.3% -0.5pp | 9.8% -4.8pp | 14.6% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $0 +12.5% | $0 +33.3% | $0 +0.0% | $0 -20.0% | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $0 +12.5% | $0 +33.3% | $0 +0.0% | $0 -20.0% | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $4.5B -1.9% | $4.6B -1.4% | $4.6B +0.3% | $4.6B +0.0% | $4.6B | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $4.5B -1.8% | $4.6B -1.0% | $4.6B +0.3% | $4.6B +0.0% | $4.6B | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.81B
Cardinal Health, Inc.
NYSE:CAH
$52.30B
Takeda Pharmaceutical Company Limited
NYSE:TAK
$50.48B
Humana Inc.
NYSE:HUM
$45.43B
Agilent Technologies, Inc.
NYSE:A
$36.56B
Zoetis Inc.
NYSE:ZTS
$33.66B
Alcon Inc.
NYSE:ALC
$32.51B
IQVIA Holdings Inc.
NYSE:IQV
$29.85B
ResMed Inc.
NYSE:RMD
$28.03B
Insmed Incorporated
NASDAQ:INSM
$21.22B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does HLN generate?
Haleon plc (HLN) reported $10.79B of revenue in fiscal 2025.
Is HLN profitable?
Haleon plc (HLN) reported $1.63B of net income, with a net margin of 15.1%.
Explore More
Continue the stock analysis
Jump to another research area for this company.